Clinical evidence for VEGF being critical for toxin clearance from the brain and better cognitive function can be appreciated from the presence of strong correlations between cognitive function (ADAS-cog performance) and CSF levels of VEGF, t-tau, and p-tau in AD subjects (Figure 3). This evidence concerns the gene MAPT and Alzheimer disease.